P1169 EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)
Zarebska-Michaluk, D, Flisiak, R, Janczewska, E, Berak, H, Dobracka, B, Librant-Suska, M, Kozielewicz, D, Lojewski, W, Jurczyk, K, Lapinski, T, Musialik, J, Postawa-Klosinska, B, Wroblewski, J, Augustyniak, K, Dudziak, M, Olszok, I, Ruszala, A, Kryczka, W, Pisula, A, Horban, A, Dobracki, W
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS
Janczewska, E, Flisiak, R, Berak, H, Zarebska-Michaluk, D, Dobracka, B, Pisula, A, Horban, A, Kryczka, W, Dobracki, W, Librant-Suska, M, Kozielewicz, D, Lojewski, W, Jurczyk, K, Lapinski, T, Musialik, J, Postawa-Klosinska, B, Wroblewski, J, Augustyniak, K, Dudziak, M, Olszok, I, Ruszala, A
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
Treatment of HCV infection in Poland at the beginning of the interferon‐free era—the EpiTer‐2 study
Flisiak, R., Zarębska‐Michaluk, D., Janczewska, E., Staniaszek, A., Gietka, A., Mazur, W., Tudrujek, M., Tomasiewicz, K., Belica‐Wdowik, T., Baka‐Ćwierz, B., Dybowska, D., Halota, W., Lorenc, B., Sitko, M., Garlicki, A., Berak, H., Horban, A., Orłowska, I., Simon, K., Socha, Ł., Wawrzynowicz‐Syczewska, M., Jaroszewicz, J., Deroń, Z., Czauż‐Andrzejuk, A., Citko, J., Krygier, R., Piekarska, A., Laurans, Ł., Dobracki, W., Białkowska, J., Tronina, O., Pawłowska, M.
Published in Journal of viral hepatitis (01.06.2018)
Published in Journal of viral hepatitis (01.06.2018)
Get full text
Journal Article
Assessment of interferon production in patients with chronic nonviral diseases by whole blood or whole bone marrow techniques
Inglot, A D, Piasecki, E, Szulc, B, Groehlich, B, Dobracki, W, Gładysz, A, Leszek, J, Szklarz, E, Sciborski, R
Published in Archivum Immunologiae et Therapiae Experimentalis (1988)
Get more information
Published in Archivum Immunologiae et Therapiae Experimentalis (1988)
Journal Article
Low level of HBV-DNA is the most powerful predictive factor of better response to IFN-α therapy in chronic hepatitis B
Simon, K., Gładysz, A., Zalewska, M., Rotter, K., Dobracki, W., Głowacki, A., Inglot, M., Knysz, B., Machaj, A., Piszko, P.
Published in Journal of hepatology (1998)
Published in Journal of hepatology (1998)
Get full text
Journal Article
Therapeutic efficacy of low-dose alpha interferon therapy in liver cirrhosis associated with HBV
Simon, K, Gładysz, A, Rotter, K, Głowacki, A, Dobracki, W, Knysz, B, Inglot, M, Mach, G, Machaj, A, Piszko, P, Zalewska, M
Published in Polskie archiwum medycyny wewne̦trznej (01.06.1998)
Get more information
Published in Polskie archiwum medycyny wewne̦trznej (01.06.1998)
Journal Article
The interferon system in chronic brucellosis
Dobracki, W, Inglot, A D, Gładysz, A, Dobracka, B, Molin, I
Published in Przegląd epidemiologiczny (1991)
Get more information
Published in Przegląd epidemiologiczny (1991)
Journal Article
Lyme disease
Groehlich, B, Dobracki, W, Leszek, J, Gładysz, A
Published in Polski tygodnik lekarski (Warsaw, Poland : 1960) (18.07.1988)
Get more information
Published in Polski tygodnik lekarski (Warsaw, Poland : 1960) (18.07.1988)
Journal Article